SPAG9-MBTD1 Fusion FISH Probe
The SPAG9-MBTD1 Fusion FISH Probe is used to confirm a fusion of the SPAG9 and MBTD1 genes. The fusion of the SPAG9 and MBTD1 genes has been associated with Ovarian Serous Cystadenocarcinoma, and Stomach Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| SPAG9-MBTD1-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| SPAG9-MBTD1-20-RERE | 20 (40 μL) | 200 μL |
|
|
| SPAG9-MBTD1-20-REOR | 20 (40 μL) | 200 μL |
|
|
| SPAG9-MBTD1-20-REGO | 20 (40 μL) | 200 μL |
|
|
| SPAG9-MBTD1-20-REGR | 20 (40 μL) | 200 μL |
|
|
| SPAG9-MBTD1-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| SPAG9-MBTD1-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| SPAG9-MBTD1-20-OROR | 20 (40 μL) | 200 μL |
|
|
| SPAG9-MBTD1-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| SPAG9-MBTD1-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| SPAG9-MBTD1-20-GORE | 20 (40 μL) | 200 μL |
|
|
| SPAG9-MBTD1-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| SPAG9-MBTD1-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| SPAG9-MBTD1-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| SPAG9-MBTD1-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| SPAG9-MBTD1-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| SPAG9-MBTD1-20-GROR | 20 (40 μL) | 200 μL |
|
|
| SPAG9-MBTD1-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| SPAG9-MBTD1-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| SPAG9-MBTD1-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| SPAG9-MBTD1-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| SPAG9-MBTD1-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| SPAG9-MBTD1-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| SPAG9-MBTD1-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| SPAG9-MBTD1-20-AQAQ | 20 (40 μL) | 200 μL |
|
SPAG9 Gene Summary
This gene encodes a member of the cancer testis antigen gene family. The encoded protein functions as a scaffold protein that structurally organizes mitogen-activated protein kinases and mediates c-Jun-terminal kinase signaling. This protein also binds to kinesin-1 and may be involved in microtubule-based membrane transport. This protein may play a role in tumor growth and development. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Oct 2011]
Gene Name: Sperm Associated Antigen 9
Chromosome: CHR17: 49039534 -49198226
Locus: 17q21.33
MBTD1 Gene Summary
The Mbt Domain Containing 1 (MBTD1) gene is located on chr17 :49254785-49337427 at 17q21.33.
Gene Name: Mbt Domain Containing 1
Chromosome: CHR17: 49254785 -49337427
Locus: 17q21.33
Gene Diseases
The SPAG9 MBTD1 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Ovarian Serous Cystadenocarcinoma |
| Stomach Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|